Related by context. Frequent words. (Click for all words.) 75 Initiates Phase II 72 Completes Patient Enrollment 69 orBec ® oral beclomethasone 69 Presents Positive 68 Receives Orphan Drug Designation 68 R sorafenib tablets 68 Enrolls First 68 oncolytic virus therapies 67 peripherally acting 67 HepeX B 67 Unit Dose Budesonide 67 2 methoxyestradiol 66 novel antibody therapeutics 66 Inc Therapeutic Competitors 66 topical non steroidal 66 Completes Enrollment 66 overactive bladder AA# 65 VEGFR2 inhibitor 65 liposomal formulation 65 synthetic retinoid 65 Currently RegeneRx 65 Commences Phase 65 TLR9 agonist 65 topical anti infective 65 Inhalation Aerosol 65 Inc. NASDAQ MBLX 65 Initiates Phase 65 treat male hypogonadism 65 candidate ridaforolimus 65 Announces Licensing Agreement 64 Auxilium transmucosal film 64 ® bortezomib 64 Panzem R 64 Prism Pharmaceuticals 64 signal detection CTSD 64 FDA Accepts 64 Meets Primary Endpoint 64 Fortical R 64 www.antigenexpress.com 64 Omigard TM 64 FACTIVE R gemifloxacin 64 Files Shelf Registration Statement 64 AeroLEF R 64 developing Zerenex TM 64 Cinryze ™ 64 Kuvan R 64 www.vivus.com 64 BiovaxID TM 64 Xanafide 64 BYETTA ® 63 sorafenib tablets 63 Announces FDA Clearance 63 Lipid Polymer Micelle LPM 63 refractory chronic lymphocytic 63 Lumacan 63 leading lipid nanoparticle 63 MKC# 63 Civacir 63 www.nymox.com email info@nymox.com 63 Testim R 63 Methylnaltrexone 63 orally disintegrating tablets 63 Wound Dressing 63 FDA Clears 63 candidate Zenvia 63 ALN PCS 63 please visit http:/www.supergen.com 63 XL# XL# XL# XL# 63 orally disintegrating tablet 63 BiTE R 63 Omacetaxine 63 novel anti infective 63 Biodefense Division 62 theranostic 62 DRRX 62 Idera Pharmaceuticals 62 low toxicity bioscience 62 gets USFDA nod 62 dipropionate 62 Emergent marketed 62 Onalta 62 proprietary adenovector technology 62 Romidepsin 62 Inc. Nasdaq IMGN 62 BioGlue R 62 commercializing therapeutic 62 Pivotal Phase III 62 Belimumab 62 Soliris TM eculizumab 62 Therapeutic Competitors 62 Transdel Pharmaceuticals Inc. 62 stable nucleic acid 62 Announces Initiation 62 VIAject R 62 www.combinatorx.com 62 immunotherapeutic agent 62 Daclizumab 62 proteasome inhibitor 62 Tesetaxel 62 post herpetic neuralgia PHN 62 topically delivered